University research records
University of Cyprus
6 imported, source-linked research records. Open-access records.
Open-access records
Back to university profile →6 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to University of Cyprus are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–6 of 6 matching records. Counts update as records arrive.
Genetic variation in antidiabetic drug targets: associations with Parkinson’s disease risk and age at onset
May 28, 2026 · 0 citations · Open access
Open original record →Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
August 29, 2022 · 129 citations · Open access
Open original record →Diabetes Mellitus and Heart Failure
August 19, 2021 · 62 citations · Open access
Open original record →European Society of Cardiology/Heart Failure Association Position Paper on the Role and Safety of New Glucose-Lowering Drugs in Patients with Heart Failure
December 9, 2019 · 178 citations · Open access
Open original record →Evaluation of the Effects of Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin on Morbidity and Mortality in Patients with Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR-Preserved Trial
September 16, 2019 · 252 citations · Open access
Open original record →Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology
May 26, 2019 · 613 citations · Open access
Open original record →